Biogen annual operating margin
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Biogen's operating margin was 25.87% for fiscal 2021.
View full Biogen company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2021 | 2021-12-31 | 25.87% | −7.98 pp |
| 2020 | 2020-12-31 | 33.84% | −15.14 pp |
| 2019 | 2019-12-31 | 48.98% | +5.21 pp |
| 2018 | 2018-12-31 | 43.77% | +0.22 pp |
| 2017 | 2017-12-31 | 43.55% | −1.44 pp |
| 2016 | 2016-12-31 | 45.00% | −0.44 pp |
| 2015 | 2015-12-31 | 45.44% | +4.50 pp |
| 2014 | 2014-12-31 | 40.94% | +4.65 pp |
| 2013 | 2013-12-31 | 36.29% | +2.65 pp |
| 2012 | 2012-12-31 | 33.64% | −0.52 pp |
| 2011 | 2011-12-31 | 34.16% | +7.68 pp |
| 2010 | 2010-12-31 | 26.48% | −3.11 pp |
| 2009 | 2009-12-31 | 29.59% | −0.02 pp |
| 2008 | 2008-12-31 | 29.62% | +5.03 pp |
| 2007 | 2007-12-31 | 24.59% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2022 | 2022-03-31 | 24.12% | −12.03 pp |
| Q4 2021 | 2021-12-31 | 21.48% | +33.07 pp |
| Q3 2021 | 2021-09-30 | 28.57% | −3.61 pp |
| Q2 2021 | 2021-06-30 | 17.50% | −36.13 pp |
| Q1 2021 | 2021-03-31 | 36.15% | −15.34 pp |
| Q4 2020 | 2020-12-31 | −11.59% | −60.01 pp |
| Q3 2020 | 2020-09-30 | 32.18% | −17.99 pp |
| Q2 2020 | 2020-06-30 | 53.63% | −0.45 pp |
| Q1 2020 | 2020-03-31 | 51.49% | +8.43 pp |
| Q4 2019 | 2019-12-31 | 48.42% | +7.50 pp |
| Q3 2019 | 2019-09-30 | 50.17% | +0.81 pp |
| Q2 2019 | 2019-06-30 | 54.08% | +17.93 pp |
| Q1 2019 | 2019-03-31 | 43.06% | −5.95 pp |
| Q4 2018 | 2018-12-31 | 40.92% | −3.41 pp |
| Q3 2018 | 2018-09-30 | 49.36% | −4.37 pp |
| Q2 2018 | 2018-06-30 | 36.14% | −2.87 pp |
| Q1 2018 | 2018-03-31 | 49.01% | +12.56 pp |
| Q4 2017 | 2017-12-31 | 44.34% | +13.43 pp |
| Q3 2017 | 2017-09-30 | 53.74% | +5.52 pp |
| Q2 2017 | 2017-06-30 | 39.01% | −11.45 pp |
| Q1 2017 | 2017-03-31 | 36.46% | −14.09 pp |
| Q4 2016 | 2016-12-31 | 30.90% | −10.24 pp |
| Q3 2016 | 2016-09-30 | 48.22% | −1.16 pp |
| Q2 2016 | 2016-06-30 | 50.46% | +2.88 pp |
| Q1 2016 | 2016-03-31 | 50.55% | +6.80 pp |
| Q4 2015 | 2015-12-31 | 41.14% | −2.78 pp |
| Q3 2015 | 2015-09-30 | 49.38% | +3.49 pp |
| Q2 2015 | 2015-06-30 | 47.58% | +6.75 pp |
| Q1 2015 | 2015-03-31 | 43.75% | +12.23 pp |
| Q4 2014 | 2014-12-31 | 43.92% | +10.45 pp |
| Q3 2014 | 2014-09-30 | 45.89% | +8.44 pp |
| Q2 2014 | 2014-06-30 | 40.83% | +2.39 pp |
| Q1 2014 | 2014-03-31 | 31.52% | −4.55 pp |
| Q4 2013 | 2013-12-31 | 33.47% | +2.05 pp |
| Q3 2013 | 2013-09-30 | 37.45% | −1.18 pp |
| Q2 2013 | 2013-06-30 | 38.44% | +2.85 pp |
| Q1 2013 | 2013-03-31 | 36.08% | +7.49 pp |
| Q4 2012 | 2012-12-31 | 31.42% | +0.58 pp |
| Q3 2012 | 2012-09-30 | 38.63% | +1.34 pp |
| Q2 2012 | 2012-06-30 | 35.59% | +1.60 pp |
| Q1 2012 | 2012-03-31 | 28.59% | −6.01 pp |
| Q4 2011 | 2011-12-31 | 30.84% | +1.70 pp |
| Q3 2011 | 2011-09-30 | 37.29% | +20.78 pp |
| Q2 2011 | 2011-06-30 | 33.99% | +1.35 pp |
| Q1 2011 | 2011-03-31 | 34.59% | +7.21 pp |
| Q4 2010 | 2010-12-31 | 29.14% | −4.88 pp |
| Q3 2010 | 2010-09-30 | 16.51% | −17.77 pp |
| Q2 2010 | 2010-06-30 | 32.64% | +12.26 pp |
| Q1 2010 | 2010-03-31 | 27.39% | −2.03 pp |
| Q4 2009 | 2009-12-31 | 34.02% | +2.37 pp |
| Q3 2009 | 2009-09-30 | 34.29% | +4.41 pp |
| Q2 2009 | 2009-06-30 | 20.39% | — |
| Q1 2009 | 2009-03-31 | 29.42% | — |
| Q3 2008 | 2008-09-30 | 31.64% | — |
| Q2 2008 | 2008-06-30 | 29.88% | — |
Over the last five reported fiscal years, Biogen's operating margin decreased from 45.00% to 25.87%, a change of −19.13 percentage points. The latest reported quarter, Q1 2022, shows 24.12%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biogen filings at SEC.gov ↗